In­tra-Cel­lu­lar aims to raise $500M; Lil­ly’s Pre­vail cuts three part­nered pro­grams

Plus, news about TScan Ther­a­peu­tics, Con­nect Bio­Phar­ma, The­olyt­ics and Ul­ti­movacs:

In­tra-Cel­lu­lar Ther­a­pies seeks $500M of­fer­ing: Short­ly af­ter dis­clos­ing a Phase 3 win …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER